Istituto Ortopedico Rizzoli
Bologna, 40136, Italy
NCT Number: NCT03086603
The study is aimed at observe how spinal anesthesia modifies the hemodynamic state of the patient after optimization to preload independence with a Goal Directed Therapy algorithm guided by non invasive hemodynamic monitoring with Clearsight.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Observational
Bologna, 40136, Italy
This is an observational prospective single group study.
Patients will be monitored with ECG (III leads), non invasive blood pressure cuff (NIBP) cuff, pulse oximetry and Clearsight finger cuff after their arrival in the operating room. Basal Stroke Volume (SV) and indexed Stroke Volume (SVI) will be registered.
The basal value will be optimized according to the study goal directed fluid therapy algorithm: a 200ml fluid challenge will be administered until the SV will increase of at least 10%. When the SV will stop increasing significantly after crystalloid administration, the SV and SVI value will be registered as SVoptimized (SVopt) and SVI optimized (SVIopt), while the same values trigger of the last fluid challenge will be registered as SVtarget1 and SVItarget1. A constant infusion of crystalloids 2 ml/Kg/h will be maintained throughout the study period.
Then, spinal anesthesia will be administered (levobupivacaine 0.5% 0.25mg/kg of ideal weight) in lateral decubitus. After 15 minutes, patients will be turned supine and after 5 minutes SV and SVI will be registered and compared with values SVtarget1 and SVItarget1: if within 10% of range, data will be registered as SVtarget2 and SVItarget2 and patient will maintain basal crystalloid infusion. Otherwise, patients will receive a fluid optimization similar to what described previously before spinal, until values will be within 10% of range of SV and SVI.
Afterwards patients will be transferred to the operating room and will be followed as described in Figure 2. At the end of surgery, patients will be transferred to the Recovery Room and will be monitored and optimized.
When patients will reach an Aldrete's Score ≥ 9/10 and a Bromage's score = 0 with sensibility restored at S1, we will compare SV and SVI value with SVtarget1 and SVItarget1 and treated accordingly.
Spontaneous micturition will be tested and in case a bladder volume > 600ml will be detected with ultrasound before recovery room discharge criteria fulfillment, we will proceed with urinary catheterization.
At patient discharge from the Recovery Room the study will be completed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: duration of spinal anesthesia procedure
stroke volume and stroke volume index variation after spinal anesthesia
Time frame: duration of spinal anesthesia procedure
cardiac output and cardiac index variation after spinal anesthesia
Time frame: duration of spinal anesthesia procedure
peripheral vascular resistance index variation after spinal anesthesia
Time frame: duration of surgery
variation of Mean Arterial Pressure (MAP) +/- 30% os basal value
Istituto Ortopedico Rizzoli
Other
Prospective Observational Study About Variation of Principal Hemodynamic Parameters, Collected With Non-invasive Monitoring, in Patients Undergoing Spinal Anesthesia for Primary Elective Hip Arthroplasty.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05054452
Critical Illness, Disease Attributes
Le Kremlin-Bicêtre, France
View Trial DetailsNCT07684989
Anesthesia, Spinal, Bupivacaine
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07260890
Digestive System Diseases, Fluid Therapy
Iksan, Jeollabuk-do, South Korea
View Trial DetailsNCT04964492
Cardiovascular Diseases, Hemodynamics
Amiens, France
View Trial Details